Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Phil Nadeau is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/08/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/21/2024 | KURA | Buy Now | Kura Oncology | $5.70 | — | Phil Nadeau65% | — | Reiterates | → Buy | Get Alert |
| 11/13/2024 | SYRS | Buy Now | Syros Pharmaceuticals | $0.02 | — | Phil Nadeau65% | — | Downgrade | Buy → Hold | Get Alert |
| 11/06/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $57.99 | 12.08% | Phil Nadeau65% | $55 → $65 | Maintains | Buy | Get Alert |
| 10/31/2024 | BIIB | Buy Now | Biogen | $115.44 | 138.23% | Phil Nadeau65% | $300 → $275 | Maintains | Buy | Get Alert |
| 08/06/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $56.52 | 112.31% | Phil Nadeau65% | $125 → $120 | Maintains | Buy | Get Alert |
| 07/23/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $474.14 | 5.45% | Phil Nadeau65% | $450 → $500 | Maintains | Buy | Get Alert |
| 08/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $474.14 | -21.96% | Phil Nadeau65% | $360 → $370 | Maintains | Outperform | Get Alert |
| 06/28/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $474.14 | -24.07% | Phil Nadeau65% | $350 → $360 | Maintains | Outperform | Get Alert |
| 05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $474.14 | -26.18% | Phil Nadeau65% | $330 → $350 | Maintains | Outperform | Get Alert |
| 03/03/2023 | ELVN | Buy Now | Enliven Therapeutics | $17.30 | — | Phil Nadeau65% | — | Initiates | → Outperform | Get Alert |
| 02/23/2023 | GRPH | Buy Now | Graphite Bio | — | — | Phil Nadeau65% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 02/16/2023 | BIIB | Buy Now | Biogen | $115.44 | 172.88% | Phil Nadeau65% | $300 → $315 | Maintains | Outperform | Get Alert |
| 10/28/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $474.14 | -30.4% | Phil Nadeau65% | $315 → $330 | Maintains | Outperform | Get Alert |
| 10/24/2022 | PHAS | Buy Now | PhaseBio Pharmaceuticals | — | — | Phil Nadeau65% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/24/2022 | TCDA | Buy Now | Tricida | — | — | Phil Nadeau65% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/21/2022 | BIIB | Buy Now | Biogen | $115.44 | 133.9% | Phil Nadeau65% | $285 → $270 | Maintains | Outperform | Get Alert |
| 07/07/2022 | MLTX | Buy Now | MoonLake | $32.92 | — | Phil Nadeau65% | — | Initiates | → Outperform | Get Alert |
| 06/13/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $474.14 | -34.62% | Phil Nadeau65% | $305 → $310 | Maintains | Outperform | Get Alert |
| 11/23/2021 | AURA | Buy Now | Aura Biosciences | $5.46 | — | Phil Nadeau65% | — | Initiates | → Outperform | Get Alert |
| 10/21/2021 | BIIB | Buy Now | Biogen | $115.44 | 224.86% | Phil Nadeau65% | $450 → $375 | Maintains | Outperform | Get Alert |
| 08/23/2021 | ICVX | Buy Now | Icosavax | — | — | Phil Nadeau65% | — | Initiates | → Outperform | Get Alert |
| 07/20/2021 | GRPH | Buy Now | Graphite Bio | — | — | Phil Nadeau65% | — | Initiates | → Outperform | Get Alert |
| 07/13/2021 | AMAM | Buy Now | Ambrx Biopharma | — | — | Phil Nadeau65% | — | Initiates | → Outperform | Get Alert |
| 11/09/2020 | BIIB | Buy Now | Biogen | $115.44 | 86.25% | Phil Nadeau65% | → $215 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/18/2020 | ANNX | Buy Now | Annexon | $1.57 | — | Phil Nadeau65% | — | Initiates | → Outperform | Get Alert |
| 07/21/2020 | AKUS | Buy Now | Akouos | — | — | Phil Nadeau65% | — | Initiates | → Outperform | Get Alert |
| 10/23/2019 | BIIB | Buy Now | Biogen | $115.44 | 181.54% | Phil Nadeau65% | $275 → $325 | Maintains | Outperform | Get Alert |
| 07/16/2018 | KZR | Buy Now | Kezar Life Sciences | $4.09 | — | Phil Nadeau65% | — | Initiates | → Outperform | Get Alert |
| 04/23/2018 | FIXX | Buy Now | Homology Medicines | — | — | Phil Nadeau65% | — | Initiates | → Outperform | Get Alert |
| 10/30/2017 | RYTM | Buy Now | Rhythm Pharmaceuticals | $57.99 | -31.03% | Phil Nadeau65% | → $40 | Initiates | → Outperform | Get Alert |
| 07/19/2017 | VRTX | Buy Now | Vertex Pharmaceuticals | $474.14 | — | Phil Nadeau65% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 05/26/2017 | IMMU | Buy Now | Immunomedics | — | — | Phil Nadeau65% | → $15 | Initiates | → Outperform | Get Alert |
